 |
42 Diseases |  |
12 Trials |
|
12 Trials |  |
1286 News |  |
| «12...3456789101112131415 |
- lisdexamfetamine / Generic mfg.
Trial withdrawal: Safety and Efficacy of SPD489 in Adolescent Subjects Aged 13-17 Years With Attention-Deficit/Hyperactivity Disorder (ADHD) (clinicaltrials.gov) - Jan 18, 2012
P3, N=0, Withdrawn, Sponsor: Shire Development LLC
Terminated --> Withdrawn
- lisdexamfetamine / Generic mfg.
Trial initiation date: Omega-3 Fatty Acid Supplementation to ADHD Pharmacotherapy in ADHD Adults With Deficient Emotional Self-Regulation Traits (clinicaltrials.gov) - Jan 17, 2012
P2, N=30, Recruiting, Sponsor: Massachusetts General Hospital
Terminated --> Withdrawn Initiation date: Sep 2011 --> Feb 2012
- lisdexamfetamine / Generic mfg.
Enrollment open: Open-Label Pilot Study of Lisdexamfetamine for Cocaine Dependence (clinicaltrials.gov) - Jan 3, 2012
P1/2, N=12, Recruiting, Sponsor: New York State Psychiatric Institute
Initiation date: Sep 2011 --> Feb 2012 Not yet recruiting --> Recruiting
- lisdexamfetamine / Generic mfg.
New P1/2 trial: Pilot Study of Lisdexamfetamine for Treatment of Cocaine Dependence (clinicaltrials.gov) - Dec 8, 2011
P1/2, N=5, Completed, Sponsor: University of Minnesota - Clinical and Translational Science Institute
- lisdexamfetamine / Generic mfg.
New P1/2 trial: Open-Label Pilot Study of Lisdexamfetamine for Cocaine Dependence (clinicaltrials.gov) - Dec 5, 2011
P1/2, N=12, Recruiting, Sponsor: New York State Psychiatric Institute
- | lisdexamfetamine / Generic mfg.
Trial completion: Double-blind, Placebo-controlled, Randomised Withdrawal, Extension, Safety and Efficacy Study of LDX in Children and Adolescents Aged 6-17 (clinicaltrials.gov) - Dec 1, 2011
P3, N=276, Completed, Sponsor: Shire Development LLC
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- lisdexamfetamine / Generic mfg.
Enrollment change: Pilot Study of Vyvanse (clinicaltrials.gov) - Nov 27, 2011
P4, N=8, Completed, Sponsor: New York State Psychiatric Institute
Active, not recruiting --> Completed N=30 --> 8
- lisdexamfetamine / Generic mfg.
New P1 trial: Assess the Safety and Pharmacokinetics of Ascending, Multiple Oral Doses of SPD489 in Adults With Schizophrenia (clinicaltrials.gov) - Oct 19, 2011
P1, N=31, Completed, Sponsor: Shire Development LLC
- || lisdexamfetamine / Generic mfg.
New P3 trial, Combination therapy: SPD489 Adult Major Depressive Disorder (MDD) Open-label Safety and Tolerability Rollover Extension Study (clinicaltrials.gov) - Sep 15, 2011
P3, N=1571, Terminated, Sponsor: Shire
- || lisdexamfetamine / Generic mfg.
New P3 trial, Combination therapy: Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder (clinicaltrials.gov) - Sep 15, 2011
P3, N=1105, Completed, Sponsor: Shire Development LLC
- || lisdexamfetamine / Generic mfg.
New P3 trial, Combination therapy: Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder (clinicaltrials.gov) - Sep 15, 2011
P3, N=1262, Completed, Sponsor: Shire Development LLC
- | lisdexamfetamine / Generic mfg.
New P2 trial, Combination therapy: SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder (clinicaltrials.gov) - Sep 15, 2011
P2, N=1197, Completed, Sponsor: Shire Development LLC
- lisdexamfetamine / Generic mfg.
Trial withdrawal: NSS: SPD489 as Adjunctive Treatment in Adults With Negative Symptoms of Schizophrenia (clinicaltrials.gov) - Sep 5, 2011
P3, N=0, Withdrawn, Sponsor: Shire Development LLC
N=30 --> 8 Not yet recruiting --> Withdrawn
- lisdexamfetamine / Generic mfg.
Enrollment change: Effect of Vyvanse on Driving in Young Adults With ADHD (clinicaltrials.gov) - Aug 23, 2011
P4, N=75, Completed, Sponsor: Massachusetts General Hospital
Not yet recruiting --> Withdrawn N=60 --> 75
- lisdexamfetamine / Generic mfg.
New P4 trial: Phase 4, Open Label, Multicentre, 2 Year Safety Study of Lisdexamfetamine Dimesylate in Children/Adolescents With ADHD (clinicaltrials.gov) - Aug 8, 2011
P4, N=12, Not yet recruiting, Sponsor: Maastricht University Medical Center